ADVERTISEMENTs
.png)
Global experts laud India’s progress against TB
The Fund also commended the Indian government and the Indian private sector for their extraordinary advances in fighting infectious diseases
Public health leaders & pharma industry experts from around the world gathered for the Global Fund-India Summit 2023, highlighting India's strategic partnership in combating TB, Malaria & HIV globally / Global Fund
Public health leaders and pharma industry experts from around the world applauded the significant progress India has made in recent years in the fight against Tuberculosis (TB) at the first Global Fund -India summit held recently in New Delhi.
The gathering also appreciated Prime Minister Narendra Modi’s extraordinary leadership in setting 2025 as India’s goal to end TB – a full five years ahead of the Sustainable Development Goal target.
World experts also commended the Indian government and the Indian private sector for their extraordinary advances in fighting infectious diseases and their to help expand Indian solutions on a global scale. They said that Indian innovations have the potential to save millions around the world.
The summit, organised on the heels of the G20 health ministers meeting from August 18-19, served as a platform for discussions, knowledge sharing, and strategic planning with the goal to scale Indian health care solutions globally, particularly those related to health products, digital health and TB.
“As the world’s leading pharmacy, India furnishes affordable medicines to over 20% of the global population. Amid the pandemic, India supplied 2.2 billion vaccines, reinforcing our steadfast dedication to accessible healthcare. Our pioneering digital infrastructure fosters connectivity and innovation. Let us march forward united, armed with innovative solutions, to carve a healthier, more resilient global future,” said Amitabh Kant, G20 Sherpa, Government of India.
Emphasizing the Global Fund’s partnership with India, Lady Roslyn Morauta, chair, Global Fund said, “Amid vibrant discussions at the G20 Health Ministers Meeting, India’s G20 leadership has been exemplary. Our partnership in India, directly supporting the national programs in HIV, TB and Malaria through grants to government and non-governmental organisations, reflects our commitment as a strategic partner in the fight against these three infectious diseases.’”
“These sessions have illuminated a clear path toward a more inclusive and responsive healthcare landscape. By embracing collaboration, innovation, and equity, we are better equipped to effectively tackle global health challenges. The potential of digital transformations to revolutionize healthcare delivery, bridge gaps, and ensure access to quality services for all cannot be overstated. Said Mark Edington, Head Grant Management, Global Fund.
In the concluding session, the participants renewed their commitment to accelerating the end of AIDS, TB and malaria. Collaborative efforts, innovative solutions, and robust investments were identified as pivotal components in achieving this shared vision.
The Global Fund reiterated its dedication to working with the government of India, the private sector, additional partners and communities to transform commitments into impactful actions that will shape a healthier and more equitable future for all.
ADVERTISEMENT
ADVERTISEMENT
E Paper
Video
.png)
.png)
.png)
.jpeg)
.jpg)
.jpg)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login